Clinical Trial: Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Study Status: Completed
Recruit Status: RECRUITING
Condition: Opioid Use Disorder
Study Type: INTERVENTIONAL
Official Title: Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder: a Randomized Double-blind Trial
Brief Summary:
This study will examine the effect of a single high dose of psilocybin therapy (30 mg) versus a very low dose (1 mg) as an adjunctive therapy to individuals undergoing standard-of-care buprenorphine treatment for Opioid use disorder (OUD).Effects of adjunctive psilocybin will be determined for longitudinal outcomes of opioid abstinence, compliance with buprenorphine maintenance, quality of life, and mood.
Read more